BSE filing, BSE: 544091. Summary written from the filing by ALFA Finder's alert engine.
Qualitek Labs Ltd: key numbers
- Share price
- ₹499.50
- Market cap
- ₹498.5 Cr
- Revenue (annual)
- ₹124.5 Cr
- Net profit (annual)
- ₹13.62 Cr
- P/E (TTM)
- 36.6×Sector 43.1×
- Promoter holding
- 56.46%
- FII holding
- 1.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Qualitek Labs Ltd
All →Qualitek Labs Bags New Order from Bio-Resources Development Centre, Government of Meghalaya
Qualitek Labs' subsidiary Interstellar Testing Centre received a work order from BRDC, Government of Meghalaya for laboratory setup and accreditation. Value is undisclosed citing commercial confidentiality.
- From
- Bio-Resources Development Centre (BRDC), Government of Meghalaya
Qualitek Labs Annual General Meeting
Qualitek Labs issued a corrigendum to its EGM notice scheduled for October 16, 2026. The amendment clarifies shareholding pattern disclosures related to the proposed preferential allotment.
Qualitek Labs Other Announcement
Qualitek Labs Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations for the period ended September 30, 2026.
Qualitek Labs Annual General Meeting
Qualitek Labs Limited held its 8th Annual General Meeting on September 25, 2026. Shareholders approved financial statements, re-appointment of the MD, and material related party transactions.
Qualitek Labs Annual General Meeting
Qualitek Labs Ltd issued an EGM notice to seek shareholder approval for a preferential issuance of 3.86 lakh equity shares and 5.20 lakh convertible warrants.
- Value
- ₹46.98 Cr
Qualitek Labs Capital Structure Change
Qualitek Labs replaced one proposed allottee in its preferential issue. The number of shares for this allocation remains unchanged at 16,000.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.